- Home
- STUB vs TMDX Comparison
STUB vs TMDX Comparison
Compare STUB & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STUB | TMDX |
|---|---|---|
| Founded | 2000 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.6B |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | STUB | TMDX |
|---|---|---|
| Price | $9.21 | $128.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | $23.50 | ★ $144.25 |
| AVG Volume (30 Days) | ★ 3.1M | 727.1K |
| Earning Date | 03-04-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 170.70 |
| EPS | N/A | ★ 2.54 |
| Revenue | ★ $1,829,430,000.00 | $566,354,000.00 |
| Revenue This Year | $2.79 | $38.73 |
| Revenue Next Year | $43.02 | $20.55 |
| P/E Ratio | ★ N/A | $51.20 |
| Revenue Growth | 14.90 | ★ 41.20 |
| 52 Week Low | $8.30 | $62.07 |
| 52 Week High | $27.89 | $156.00 |
Technical Indicators
Market Signals| Indicator | STUB | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 28.95 | 46.69 |
| Support Level | $8.30 | $127.00 |
| Resistance Level | $10.49 | $140.72 |
| Average True Range (ATR) | 1.17 | 6.52 |
| MACD | -0.47 | -0.77 |
| Stochastic Oscillator | 3.97 | 23.69 |
Price Performance
Historical ComparisonAbout STUB StubHub Holdings Inc.
Stubhub Holdings Inc is an online marketplace for secondary ticket buy and selling.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.